ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Topical Recombinant Thrombin Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-20Y17069
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Topical Recombinant Thrombin Market Research Report 2024
BUY CHAPTERS

Global Topical Recombinant Thrombin Market Research Report 2024

Code: QYRE-Auto-20Y17069
Report
April 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Octapharma AG
Octapharma
GE Healthcare
Grifols S A
Grifols
Takeda
Bayer
CSL Limited
Hualan Biological
Haematologic Technologies
OMRIX Biopharmaceuticals
Shanghai Raas

Topical Recombinant Thrombin Market

The global Topical Recombinant Thrombin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Topical Recombinant Thrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Topical Recombinant Thrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Topical Recombinant Thrombin include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Topical Recombinant Thrombin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Recombinant Thrombin.
The Topical Recombinant Thrombin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Topical Recombinant Thrombin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topical Recombinant Thrombin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Topical Recombinant Thrombin Market Report

Report Metric Details
Report Name Topical Recombinant Thrombin Market
Segment by Type
  • Based Bovine
  • Based Human
  • Others
Segment by Application
  • Hospitals
  • Diagnostics & Clinics
  • Academic and Research Institute
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Topical Recombinant Thrombin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Topical Recombinant Thrombin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Topical Recombinant Thrombin Market report?

Ans: The main players in the Topical Recombinant Thrombin Market are Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, Shanghai RAAS

What are the Application segmentation covered in the Topical Recombinant Thrombin Market report?

Ans: The Applications covered in the Topical Recombinant Thrombin Market report are Hospitals, Diagnostics & Clinics, Academic and Research Institute

What are the Type segmentation covered in the Topical Recombinant Thrombin Market report?

Ans: The Types covered in the Topical Recombinant Thrombin Market report are Based Bovine, Based Human, Others

1 Topical Recombinant Thrombin Market Overview
1.1 Product Definition
1.2 Topical Recombinant Thrombin by Type
1.2.1 Global Topical Recombinant Thrombin Market Value Comparison by Type (2024-2030)
1.2.2 Based Bovine
1.2.3 Based Human
1.2.4 Others
1.3 Topical Recombinant Thrombin by Application
1.3.1 Global Topical Recombinant Thrombin Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Global Topical Recombinant Thrombin Market Size Estimates and Forecasts
1.4.1 Global Topical Recombinant Thrombin Revenue 2019-2030
1.4.2 Global Topical Recombinant Thrombin Sales 2019-2030
1.4.3 Global Topical Recombinant Thrombin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Topical Recombinant Thrombin Market Competition by Manufacturers
2.1 Global Topical Recombinant Thrombin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Topical Recombinant Thrombin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Topical Recombinant Thrombin Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Topical Recombinant Thrombin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Topical Recombinant Thrombin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Topical Recombinant Thrombin, Product Type & Application
2.7 Global Key Manufacturers of Topical Recombinant Thrombin, Date of Enter into This Industry
2.8 Global Topical Recombinant Thrombin Market Competitive Situation and Trends
2.8.1 Global Topical Recombinant Thrombin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Topical Recombinant Thrombin Players Market Share by Revenue
2.8.3 Global Topical Recombinant Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Topical Recombinant Thrombin Market Scenario by Region
3.1 Global Topical Recombinant Thrombin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Topical Recombinant Thrombin Sales by Region: 2019-2030
3.2.1 Global Topical Recombinant Thrombin Sales by Region: 2019-2024
3.2.2 Global Topical Recombinant Thrombin Sales by Region: 2025-2030
3.3 Global Topical Recombinant Thrombin Revenue by Region: 2019-2030
3.3.1 Global Topical Recombinant Thrombin Revenue by Region: 2019-2024
3.3.2 Global Topical Recombinant Thrombin Revenue by Region: 2025-2030
3.4 North America Topical Recombinant Thrombin Market Facts & Figures by Country
3.4.1 North America Topical Recombinant Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Topical Recombinant Thrombin Sales by Country (2019-2030)
3.4.3 North America Topical Recombinant Thrombin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Topical Recombinant Thrombin Market Facts & Figures by Country
3.5.1 Europe Topical Recombinant Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Topical Recombinant Thrombin Sales by Country (2019-2030)
3.5.3 Europe Topical Recombinant Thrombin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Topical Recombinant Thrombin Market Facts & Figures by Region
3.6.1 Asia Pacific Topical Recombinant Thrombin Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Topical Recombinant Thrombin Sales by Region (2019-2030)
3.6.3 Asia Pacific Topical Recombinant Thrombin Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Topical Recombinant Thrombin Market Facts & Figures by Country
3.7.1 Latin America Topical Recombinant Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Topical Recombinant Thrombin Sales by Country (2019-2030)
3.7.3 Latin America Topical Recombinant Thrombin Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Topical Recombinant Thrombin Market Facts & Figures by Country
3.8.1 Middle East and Africa Topical Recombinant Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Topical Recombinant Thrombin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Topical Recombinant Thrombin Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Topical Recombinant Thrombin Sales by Type (2019-2030)
4.1.1 Global Topical Recombinant Thrombin Sales by Type (2019-2024)
4.1.2 Global Topical Recombinant Thrombin Sales by Type (2025-2030)
4.1.3 Global Topical Recombinant Thrombin Sales Market Share by Type (2019-2030)
4.2 Global Topical Recombinant Thrombin Revenue by Type (2019-2030)
4.2.1 Global Topical Recombinant Thrombin Revenue by Type (2019-2024)
4.2.2 Global Topical Recombinant Thrombin Revenue by Type (2025-2030)
4.2.3 Global Topical Recombinant Thrombin Revenue Market Share by Type (2019-2030)
4.3 Global Topical Recombinant Thrombin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Topical Recombinant Thrombin Sales by Application (2019-2030)
5.1.1 Global Topical Recombinant Thrombin Sales by Application (2019-2024)
5.1.2 Global Topical Recombinant Thrombin Sales by Application (2025-2030)
5.1.3 Global Topical Recombinant Thrombin Sales Market Share by Application (2019-2030)
5.2 Global Topical Recombinant Thrombin Revenue by Application (2019-2030)
5.2.1 Global Topical Recombinant Thrombin Revenue by Application (2019-2024)
5.2.2 Global Topical Recombinant Thrombin Revenue by Application (2025-2030)
5.2.3 Global Topical Recombinant Thrombin Revenue Market Share by Application (2019-2030)
5.3 Global Topical Recombinant Thrombin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Topical Recombinant Thrombin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Topical Recombinant Thrombin Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Topical Recombinant Thrombin Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols Topical Recombinant Thrombin Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Company Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GE Healthcare Topical Recombinant Thrombin Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Hualan Biological
6.6.1 Hualan Biological Company Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Biological Topical Recombinant Thrombin Product Portfolio
6.6.5 Hualan Biological Recent Developments/Updates
6.7 Haematologic Technologies
6.7.1 Haematologic Technologies Company Information
6.7.2 Haematologic Technologies Description and Business Overview
6.7.3 Haematologic Technologies Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Haematologic Technologies Topical Recombinant Thrombin Product Portfolio
6.7.5 Haematologic Technologies Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Topical Recombinant Thrombin Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Company Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Octapharma Topical Recombinant Thrombin Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Omrix Biopharmaceuticals
6.10.1 Omrix Biopharmaceuticals Company Information
6.10.2 Omrix Biopharmaceuticals Description and Business Overview
6.10.3 Omrix Biopharmaceuticals Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Omrix Biopharmaceuticals Topical Recombinant Thrombin Product Portfolio
6.10.5 Omrix Biopharmaceuticals Recent Developments/Updates
6.11 Shanghai RAAS
6.11.1 Shanghai RAAS Company Information
6.11.2 Shanghai RAAS Description and Business Overview
6.11.3 Shanghai RAAS Topical Recombinant Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai RAAS Topical Recombinant Thrombin Product Portfolio
6.11.5 Shanghai RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Topical Recombinant Thrombin Industry Chain Analysis
7.2 Topical Recombinant Thrombin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Topical Recombinant Thrombin Production Mode & Process
7.4 Topical Recombinant Thrombin Sales and Marketing
7.4.1 Topical Recombinant Thrombin Sales Channels
7.4.2 Topical Recombinant Thrombin Distributors
7.5 Topical Recombinant Thrombin Customers
8 Topical Recombinant Thrombin Market Dynamics
8.1 Topical Recombinant Thrombin Industry Trends
8.2 Topical Recombinant Thrombin Market Drivers
8.3 Topical Recombinant Thrombin Market Challenges
8.4 Topical Recombinant Thrombin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Octapharma AG
Octapharma
GE Healthcare
Grifols S A
Grifols
Takeda
Bayer
CSL Limited
Hualan Biological
Haematologic Technologies
OMRIX Biopharmaceuticals
Shanghai Raas
List of Tables
 Table 1. Global Topical Recombinant Thrombin Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Topical Recombinant Thrombin Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Topical Recombinant Thrombin Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Topical Recombinant Thrombin Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Topical Recombinant Thrombin Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Topical Recombinant Thrombin Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Topical Recombinant Thrombin Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Topical Recombinant Thrombin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Topical Recombinant Thrombin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Topical Recombinant Thrombin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Topical Recombinant Thrombin, Product Type & Application
 Table 12. Global Key Manufacturers of Topical Recombinant Thrombin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Topical Recombinant Thrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Recombinant Thrombin as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Topical Recombinant Thrombin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Topical Recombinant Thrombin Sales by Region (2019-2024) & (K Units)
 Table 18. Global Topical Recombinant Thrombin Sales Market Share by Region (2019-2024)
 Table 19. Global Topical Recombinant Thrombin Sales by Region (2025-2030) & (K Units)
 Table 20. Global Topical Recombinant Thrombin Sales Market Share by Region (2025-2030)
 Table 21. Global Topical Recombinant Thrombin Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Topical Recombinant Thrombin Revenue Market Share by Region (2019-2024)
 Table 23. Global Topical Recombinant Thrombin Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Topical Recombinant Thrombin Revenue Market Share by Region (2025-2030)
 Table 25. North America Topical Recombinant Thrombin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Topical Recombinant Thrombin Sales by Country (2019-2024) & (K Units)
 Table 27. North America Topical Recombinant Thrombin Sales by Country (2025-2030) & (K Units)
 Table 28. North America Topical Recombinant Thrombin Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Topical Recombinant Thrombin Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Topical Recombinant Thrombin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Topical Recombinant Thrombin Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Topical Recombinant Thrombin Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Topical Recombinant Thrombin Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Topical Recombinant Thrombin Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Topical Recombinant Thrombin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Topical Recombinant Thrombin Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Topical Recombinant Thrombin Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Topical Recombinant Thrombin Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Topical Recombinant Thrombin Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Topical Recombinant Thrombin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Topical Recombinant Thrombin Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Topical Recombinant Thrombin Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Topical Recombinant Thrombin Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Topical Recombinant Thrombin Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Topical Recombinant Thrombin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Topical Recombinant Thrombin Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Topical Recombinant Thrombin Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Topical Recombinant Thrombin Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Topical Recombinant Thrombin Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Topical Recombinant Thrombin Sales (K Units) by Type (2019-2024)
 Table 51. Global Topical Recombinant Thrombin Sales (K Units) by Type (2025-2030)
 Table 52. Global Topical Recombinant Thrombin Sales Market Share by Type (2019-2024)
 Table 53. Global Topical Recombinant Thrombin Sales Market Share by Type (2025-2030)
 Table 54. Global Topical Recombinant Thrombin Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Topical Recombinant Thrombin Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Topical Recombinant Thrombin Revenue Market Share by Type (2019-2024)
 Table 57. Global Topical Recombinant Thrombin Revenue Market Share by Type (2025-2030)
 Table 58. Global Topical Recombinant Thrombin Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Topical Recombinant Thrombin Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Topical Recombinant Thrombin Sales (K Units) by Application (2019-2024)
 Table 61. Global Topical Recombinant Thrombin Sales (K Units) by Application (2025-2030)
 Table 62. Global Topical Recombinant Thrombin Sales Market Share by Application (2019-2024)
 Table 63. Global Topical Recombinant Thrombin Sales Market Share by Application (2025-2030)
 Table 64. Global Topical Recombinant Thrombin Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Topical Recombinant Thrombin Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Topical Recombinant Thrombin Revenue Market Share by Application (2019-2024)
 Table 67. Global Topical Recombinant Thrombin Revenue Market Share by Application (2025-2030)
 Table 68. Global Topical Recombinant Thrombin Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Topical Recombinant Thrombin Price (US$/Unit) by Application (2025-2030)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Takeda Topical Recombinant Thrombin Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Bayer Topical Recombinant Thrombin Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. CSL Topical Recombinant Thrombin Product
 Table 84. CSL Recent Developments/Updates
 Table 85. Grifols Company Information
 Table 86. Grifols Description and Business Overview
 Table 87. Grifols Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Grifols Topical Recombinant Thrombin Product
 Table 89. Grifols Recent Developments/Updates
 Table 90. GE Healthcare Company Information
 Table 91. GE Healthcare Description and Business Overview
 Table 92. GE Healthcare Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. GE Healthcare Topical Recombinant Thrombin Product
 Table 94. GE Healthcare Recent Developments/Updates
 Table 95. Hualan Biological Company Information
 Table 96. Hualan Biological Description and Business Overview
 Table 97. Hualan Biological Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Hualan Biological Topical Recombinant Thrombin Product
 Table 99. Hualan Biological Recent Developments/Updates
 Table 100. Haematologic Technologies Company Information
 Table 101. Haematologic Technologies Description and Business Overview
 Table 102. Haematologic Technologies Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Haematologic Technologies Topical Recombinant Thrombin Product
 Table 104. Haematologic Technologies Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Pfizer Topical Recombinant Thrombin Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Octapharma Company Information
 Table 111. Octapharma Description and Business Overview
 Table 112. Octapharma Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Octapharma Topical Recombinant Thrombin Product
 Table 114. Octapharma Recent Developments/Updates
 Table 115. Omrix Biopharmaceuticals Company Information
 Table 116. Omrix Biopharmaceuticals Description and Business Overview
 Table 117. Omrix Biopharmaceuticals Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Omrix Biopharmaceuticals Topical Recombinant Thrombin Product
 Table 119. Omrix Biopharmaceuticals Recent Developments/Updates
 Table 120. Shanghai RAAS Company Information
 Table 121. Shanghai RAAS Description and Business Overview
 Table 122. Shanghai RAAS Topical Recombinant Thrombin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Shanghai RAAS Topical Recombinant Thrombin Product
 Table 124. Shanghai RAAS Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Topical Recombinant Thrombin Distributors List
 Table 128. Topical Recombinant Thrombin Customers List
 Table 129. Topical Recombinant Thrombin Market Trends
 Table 130. Topical Recombinant Thrombin Market Drivers
 Table 131. Topical Recombinant Thrombin Market Challenges
 Table 132. Topical Recombinant Thrombin Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Topical Recombinant Thrombin
 Figure 2. Global Topical Recombinant Thrombin Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Topical Recombinant Thrombin Market Share by Type: 2023 & 2030
 Figure 4. Based Bovine Product Picture
 Figure 5. Based Human Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Topical Recombinant Thrombin Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Topical Recombinant Thrombin Market Share by Application: 2023 & 2030
 Figure 9. Hospitals
 Figure 10. Diagnostics & Clinics
 Figure 11. Academic and Research Institute
 Figure 12. Global Topical Recombinant Thrombin Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Topical Recombinant Thrombin Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Topical Recombinant Thrombin Sales (2019-2030) & (K Units)
 Figure 15. Global Topical Recombinant Thrombin Average Price (US$/Unit) & (2019-2030)
 Figure 16. Topical Recombinant Thrombin Report Years Considered
 Figure 17. Topical Recombinant Thrombin Sales Share by Manufacturers in 2023
 Figure 18. Global Topical Recombinant Thrombin Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Topical Recombinant Thrombin Players: Market Share by Revenue in Topical Recombinant Thrombin in 2023
 Figure 20. Topical Recombinant Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Topical Recombinant Thrombin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Topical Recombinant Thrombin Sales Market Share by Country (2019-2030)
 Figure 23. North America Topical Recombinant Thrombin Revenue Market Share by Country (2019-2030)
 Figure 24. United States Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Topical Recombinant Thrombin Sales Market Share by Country (2019-2030)
 Figure 27. Europe Topical Recombinant Thrombin Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Topical Recombinant Thrombin Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Topical Recombinant Thrombin Revenue Market Share by Region (2019-2030)
 Figure 35. China Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Topical Recombinant Thrombin Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Topical Recombinant Thrombin Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Topical Recombinant Thrombin Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Topical Recombinant Thrombin Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Topical Recombinant Thrombin by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Topical Recombinant Thrombin by Type (2019-2030)
 Figure 54. Global Topical Recombinant Thrombin Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Topical Recombinant Thrombin by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Topical Recombinant Thrombin by Application (2019-2030)
 Figure 57. Global Topical Recombinant Thrombin Price (US$/Unit) by Application (2019-2030)
 Figure 58. Topical Recombinant Thrombin Value Chain
 Figure 59. Topical Recombinant Thrombin Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Topical Recombinant Human Thrombin Market Research Report 2024
Topical Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Tissue Plasminogen Activator Market Research Report 2024
Global Thrombin Human Market Research Report 2025
Global Recombinant Coagulation Factor IX Market Research Report 2025
Global Recombinant Factor Products Market Research Report 2024
Global Thrombin Preparation Market Research Report 2024
Recombinant Collagen Market
Global Thrombin Inhibitor Market Research Report 2024
Global Recombinant Proteinase K Market Research Report 2024
Global Recombinant Human Thrombin Protein Market Research Report 2024
Global Recombinant Factor C Assay Market Research Report 2024
Global Recombinant Growth Factors Market Research Report 2025
Global Human Thrombin Market Research Report 2024
Thrombin Time Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Topical Absorbable Hemostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antibodies rAbs Market Research Report 2024
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
Global Recombinant Protein Reagents Market Research Report 2025
Global Recombinant Protein Service Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions